Prices delayed by at least 15 minutes | Print
Perspective Therapeutics (CATX)
Common StockOpen
$1.53
Previous close
$1.53
Trade high
$1.68
Volume
5,526,230
Year high
$1.91
Year low
$0.21
Dividend yield
-
Market capitalisation
$996.21 mn
P/E ratio
-
ISIN
US46489V1044
This share can be held in a Dealing accountISALifetime ISAJISASIPP
Share price
Company profile
Perspective Therapeutics Inc is a medical technology and radiopharmaceutical company that is pioneering various treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha emitting isotope 212Pb to deliver powerful radiation specifically to cancer cells via specialized targeting peptides.
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2024 AJ Bell. All rights reserved.